EUVIMEDScopri EUVIMED
Crossref

Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?

The Internet Journal of Emergency and Intensive Care Medicine · 2007

DOI: 10.5580/1391 ↗

At a glance

Journal article in The Internet Journal of Emergency and Intensive Care Medicine, 2007.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Severe sepsis complicated by acute renal failure has a high mortality. Despite severe clinical implications, a consensus on treatment and/or prevention of ARF in this setting has yet to emerge. As a potent natriuretic, renal vasodilator, and inhibitor of renin secretion, natriuretic peptide is an attractive theoretical renoprotective agent. We present a compelling case in which recombinant b-type natriuretic peptide ( rBNP) was used as adjunctive therapy to prevent acute renal failure in severe sepsis, with apparent subsequent improvement in renal function.

Cite

APA

(2007). Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?. The Internet Journal of Emergency and Intensive Care Medicine. https://doi.org/10.5580/1391

Vancouver

Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?. The Internet Journal of Emergency and Intensive Care Medicine. 2007. doi:10.5580/1391

BibTeX
@article{euvimed2007,
  title = {Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?},
  journal = {The Internet Journal of Emergency and Intensive Care Medicine},
  year = {2007},
  doi = {10.5580/1391}
}
Start for free →